Aehr Test Systems
AEHR · NASDAQ
8/29/2025 | 5/31/2025 | 2/28/2025 | 11/29/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.15 | -0.07 | 2.95 | 0.34 |
| FCF Yield | -0.20% | -1.80% | -1.14% | -1.76% |
| EV / EBITDA | -383.74 | -137.39 | 7,513.00 | -926.16 |
| Quality | ||||
| ROIC | -2.12% | -1.70% | -0.63% | -0.95% |
| Gross Margin | 33.90% | 30.32% | 39.24% | 40.14% |
| Cash Conversion Ratio | 0.03 | 0.79 | 2.50 | 5.71 |
| Growth | ||||
| Revenue 3-Year CAGR | -8.80% | -3.17% | -0.80% | -5.99% |
| Free Cash Flow Growth | 71.52% | -57.01% | 47.35% | -383.74% |
| Safety | ||||
| Net Debt / EBITDA | 6.32 | 7.32 | -676.31 | 75.67 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.17 | 0.23 | 0.26 | 0.18 |
| Cash Conversion Cycle | 584.57 | 436.99 | 345.10 | 485.39 |